Primer: Zephyrm Bioscience (ZPB HK) - Aug 2026
Zephyrm Bioscience is a clinical-stage biopharmaceutical company focused on the development of innovative cell therapies derived from...
87 Views
Pre-IPO Zephyrm Bioscience - Despite Promising Pipeline, Investment Risk Is High
Zephyrm's pipeline has great potential, and its strategy focused on PSCs is at the forefront of the times. But the investment risk is relatively...
648 Views
No more insights